Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | CES1 | P23141 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6317668 | 0.82 | ALDH1A1 (0.38) | ALDH1A1MAPTTSHRKMT2AHSD17B10 | |
| SCHEMBL18352875 | 0.71 | CES1 (0.42) | ALDH1A1CES1MAPTTSHRKMT2A | |
| SCHEMBL6311434 | 0.70 | ALDH1A1 (0.42) | ALDH1A1TSHRHSD17B10NPSR1 | |
| SCHEMBL7453197 | 0.70 | SMN1; SMN2 (0.43) | ALDH1A1CES1MAPTTSHRKMT2A | |
| SCHEMBL6318759 | 0.69 | — | — | |
| SCHEMBL368639 | 0.68 | HSD17B10 (0.50) | ALDH1A1CES1MAPTTSHRKMT2A | |
| SCHEMBL27264408 | 0.68 | TSHR (0.42) | ALDH1A1CES1MAPTTSHRKMT2A | |
| SCHEMBL6319267 | 0.67 | — | — | |
| SCHEMBL25144949 | 0.67 | ALDH1A1 (0.40) | ALDH1A1CES1MAPTTSHRKMT2A | |
| SCHEMBL6310290 | 0.67 | MAOA (0.43) | ALDH1A1MAPTKMT2ANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050143581-A1 | Process for preparation of alkoxybenzamides and thiazolyl isocyanates | MITSUI CHEMICALS, INC. (JP) | 2005-06-30 | — | — | US | disclosed |
| EP-1489073-A1 | PROCESS FORPREPARATION OF ALKOXYBENZAMIDES AND THIAZOLYL ISOCYANATES | MITSUI CHEMICALS, INC. (JP) | 2004-12-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050143581-A1 | Process for preparation of alkoxybenzamides and thiazolyl isocyanates | CBR3, CBR1, IDH1 | ALDH1A1 65/4885CES1 792/4885MAPT 3828/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.